Immunosuppressive Ability of Trichinella spiralis Adults Can Ameliorate Type 2 Inflammation in a Murine Allergy Model.

Wenjie Shi, Qinwei Xu, Yan Liu, Zhili Hao, Yue Liang, Isabelle Vallée, Xihuo You, Mingyuan Liu, Xiaolei Liu, Ning Xu
Author Information
  1. Wenjie Shi: State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University, Changchun. ORCID
  2. Qinwei Xu: Department of Pulmonary and Critical Care Medicine, Qilu Hospital of Shandong University, Qingdao.
  3. Yan Liu: College of Public Health, Jilin Medical University, China.
  4. Zhili Hao: State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University, Changchun.
  5. Yue Liang: State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University, Changchun.
  6. Isabelle Vallée: Unité Mixte de Recherche Biologie moléculaire et Immunologie Parasitaire, Anses, Institut national de recherche pour l'agriculture, l'alimentation et l'environnement, Laboratoire de Santé Animale, Ecole Nationale Vétérinaire d'Alfort, Maisons-Alfort, France.
  7. Xihuo You: Beijing Agrichina Pharmaceutical Co, Ltd, Beijing, China.
  8. Mingyuan Liu: State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University, Changchun.
  9. Xiaolei Liu: State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University, Changchun.
  10. Ning Xu: State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University, Changchun. ORCID

Abstract

BACKGROUND: There is an increase in the global incidence of allergies. The hygiene hypothesis and the old friend hypothesis reveal that helminths are associated with the prevalence of allergic diseases. The therapeutic potential of Trichinella spiralis is recognized; however, the stage at which it exerts its immunomodulatory effect is unclear.
METHODS: We evaluated the differentiation of bone marrow-derived macrophages stimulated with T spiralis excretory-secretory products. Based on an ovalbumin-induced murine model, T spiralis was introduced during 3 allergy phases. Cytokine levels and immune cell subsets in the lung, spleen, and peritoneal cavity were assessed.
RESULTS: We found that T spiralis infection reduced lung inflammation, increased anti-inflammatory cytokines, and decreased Th2 cytokines and alarms. Recruitment of eosinophils, CD11b+ dendritic cells, and interstitial macrophages to the lung was significantly suppressed, whereas Treg cells and alternatively activated macrophages increased in T spiralis infection groups vs the ovalbumin group. Notably, when T spiralis was infected prior to ovalbumin challenge, intestinal adults promoted proportions of CD103+ dendritic cells and alveolar macrophages.
CONCLUSIONS: T spiralis strongly suppressed type 2 inflammation, and adults maintained lung immune homeostasis.

Keywords

References

  1. Nat Rev Immunol. 2021 Nov;21(11):739-751 [PMID: 33846604]
  2. Transl Res. 2018 Jan;191:1-14 [PMID: 29066321]
  3. Ann N Y Acad Sci. 1995 Sep 29;764:123-35 [PMID: 7486511]
  4. J Electron Microsc (Tokyo). 1997;46(4):347-52 [PMID: 9345776]
  5. Parasit Vectors. 2021 Mar 1;14(1):130 [PMID: 33648561]
  6. Curr Opin Immunol. 2018 Oct;54:28-34 [PMID: 29883877]
  7. Cell. 2022 Nov 10;185(23):4259-4279 [PMID: 36368305]
  8. JCI Insight. 2017 May 18;2(10): [PMID: 28515363]
  9. Curr Opin Immunol. 2018 Oct;54:1-6 [PMID: 29852470]
  10. Front Immunol. 2022 Dec 20;13:1056477 [PMID: 36605195]
  11. J Ethnopharmacol. 2020 Dec 5;263:113152 [PMID: 32755652]
  12. Allergy. 2020 Mar;75(3):524-534 [PMID: 31187881]
  13. Proc Natl Acad Sci U S A. 2022 Mar 1;119(9): [PMID: 35210367]
  14. J Exp Med. 2008 Jun 9;205(6):1285-92 [PMID: 18490489]
  15. Parasit Vectors. 2022 Oct 27;15(1):391 [PMID: 36289514]
  16. PLoS Pathog. 2021 Nov 8;17(11):e1010069 [PMID: 34748611]
  17. Elife. 2020 May 18;9: [PMID: 32420871]
  18. J Immunol. 2015 Nov 1;195(9):4059-66 [PMID: 26477048]
  19. Am J Physiol Lung Cell Mol Physiol. 2023 Apr 1;324(4):L536-L549 [PMID: 36852927]
  20. Curr Opin Immunol. 2021 Oct;72:221-229 [PMID: 34216934]
  21. Cell Mol Immunol. 2019 Mar;16(3):225-235 [PMID: 30792500]
  22. Proc Natl Acad Sci U S A. 2022 Sep 6;119(36):e2202795119 [PMID: 36037362]
  23. Front Immunol. 2020 Nov 19;11:572326 [PMID: 33329535]
  24. J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1439-1444 [PMID: 30197067]
  25. Allergy. 2022 Dec;77(12):3567-3583 [PMID: 36067034]
  26. J Immunol. 2017 Jul 1;199(1):244-252 [PMID: 28533444]
  27. J Immunol. 2014 Jul 15;193(2):496-509 [PMID: 24943219]
  28. Allergy. 2015 Jan;70(1):80-9 [PMID: 25331546]
  29. J Clin Invest. 2009 Dec;119(12):3723-38 [PMID: 19907079]
  30. Allergy. 2016 Feb;71(2):137-48 [PMID: 26427032]
  31. J Allergy Clin Immunol. 2016 Sep;138(3):666-675 [PMID: 27476889]
  32. Cell Rep. 2022 Jan 11;38(2):110215 [PMID: 35021079]
  33. Toxicol Appl Pharmacol. 1994 Mar;125(1):7-16 [PMID: 8128497]
  34. J Immunol. 2021 Mar 1;206(5):963-977 [PMID: 33495238]
  35. Vet Res. 2020 May 13;51(1):65 [PMID: 32404195]
  36. Immunity. 2013 Feb 21;38(2):322-35 [PMID: 23352232]
  37. Nature. 2016 Jan 14;529(7585):221-5 [PMID: 26675736]
  38. Front Immunol. 2016 Mar 23;7:107 [PMID: 27047494]
  39. Parasitol Res. 2016 Feb;115(2):615-22 [PMID: 26468148]
  40. PLoS Negl Trop Dis. 2014 Dec 18;8(12):e3410 [PMID: 25522145]
  41. J Inflamm Res. 2022 Jan 21;15:475-491 [PMID: 35087284]
  42. Am J Respir Cell Mol Biol. 2013 Oct;49(4):503-10 [PMID: 23672262]
  43. Methods Mol Biol. 2014;1178:1-12 [PMID: 24986602]
  44. J Allergy Clin Immunol. 2017 Nov;140(5):1217-1228 [PMID: 29108604]

Grants

  1. 2021YFC2600202/National Key Research and Development Program of China
  2. 32202835/National Nature Science Foundation of China
  3. /Science and Technology Talents and Platform Plan of Yunnan Province
  4. 202305AF150167/Academician and Expert Workstation
  5. /Fundamental Research Funds for the Central Universities

MeSH Term

Mice
Humans
Animals
Trichinella spiralis
Ovalbumin
Inflammation
Hypersensitivity
Cytokines

Chemicals

Ovalbumin
Cytokines

Word Cloud

Created with Highcharts 10.0.0spiralisTmacrophageslungTrichinellacellsovalbuminhypothesisallergicimmuneinfectioninflammationincreasedcytokinesdendriticsuppressedalternativelyactivatedadults2BACKGROUND:increaseglobalincidenceallergieshygieneoldfriendrevealhelminthsassociatedprevalencediseasestherapeuticpotentialrecognizedhoweverstageexertsimmunomodulatoryeffectunclearMETHODS:evaluateddifferentiationbonemarrow-derivedstimulatedexcretory-secretoryproductsBasedovalbumin-inducedmurinemodelintroduced3allergyphasesCytokinelevelscellsubsetsspleenperitonealcavityassessedRESULTS:foundreducedanti-inflammatorydecreasedTh2alarmsRecruitmenteosinophilsCD11b+interstitialsignificantlywhereasTreggroupsvsgroupNotablyinfectedpriorchallengeintestinalpromotedproportionsCD103+alveolarCONCLUSIONS:stronglytypemaintainedhomeostasisImmunosuppressiveAbilityAdultsCanAmeliorateTypeInflammationMurineAllergyModelasthmaimmunosuppressiveresponse

Similar Articles

Cited By